Sudarshan Pharma Industries Performance
- Today's Low
- ₹37
- Today's High
- ₹40
- 52 Week Low
- ₹19
- 52 Week High
- ₹40
- Open Price₹39
- Previous Close₹38
- Volume944,000
- 50 DMA₹33.26
- 100 DMA₹30.70
- 200 DMA₹29.18
Sudarshan Pharma Industries Chart
Investment Returns
- Over 1 Month + 17.77%
- Over 3 Month + 80.04%
- Over 6 Month + 56.75%
- Over 1 Year + 35.83%
Smart Investing Starts Here Start SIP with Sudarshan Pharma Industries for Steady Growth!
Sudarshan Pharma Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 40.8
- PEG Ratio
- 0.9
- Market Cap Cr
- 951
- P/B Ratio
- 6.1
- Average True Range
- 1.77
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.5
- RSI
- 74.92
- MFI
- 73.51
Latest Stock News Updates
The funds will be raised in one or more tranches, Sudarshan Pharma said in a regulatory filing.
- NDTV Profit
- 1 year ago
Small-cap stock below 50: Pharma stock , Sudarshan Pharma lndustries jumps 6% from lows in the stock market today on this acquisition buzz. It plans establish a wholly-owned subsidiary in Poland, a move aimed to broaden its business operations, potentially enhancing investor confidence
- livemint
- 1 year 4 months ago
Sudarshan Pharma Industries' shares increased 5% to a 52-week high of 53.50 on January 7. The company plans to discuss a fundraising strategy in its upcoming board meeting on January 10.
- livemint
- 1 year 5 months ago
Sudarshan Pharma Industries Financials
Sudarshan Pharma Industries Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹36.10
- 50 Day
- ₹33.30
- 100 Day
- ₹30.70
- 200 Day
- ₹29.20
Resistance and Support
- R3 45.22
- R2 42.82
- R1 41.38
- S1 37.54
- S2 35.14
- S3 33.70
Sudarshan Pharma Industries Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-06-18 | Issue Of Warrants | Inter-alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof per share(3%)Final Dividend |
| 2026-05-21 | Others | (Revised) Inter-alia to consider 1. Approve Migration of listing / trading of the Equity Shares. 2. Approve Postal Ballot Notice & Calendat of events for seekirg approval. 3. Other business matters. per share(3%)Final Dividend |
| 2026-05-15 | Others | Inter-alia, to consider 1. The proposal for the issuance of Foreign Currency Convertible Bonds, subject to receipt of applicable regulatory and statutory approvals. per share(3%)Final Dividend |
| 2026-04-30 | Audited Results | |
| 2026-01-28 | Quarterly Results |
About Sudarshan Pharma Industries
- NSE Symbol
- 543828
- BSE Symbol
- 543828
- Chairman & Managing Director
- Mr. Hemal Vasantrai Mehta
- ISIN
- INE00TV01023
Similar Stocks to Sudarshan Pharma Industries
Popular Stocks
Sudarshan Pharma Industries FAQs
Sudarshan Pharma Industries share price is ₹39 As on 24 June, 2026 | 19:44
The Market Cap of Sudarshan Pharma Industries is ₹950.6 Cr As on 24 June, 2026 | 19:44
The P/E ratio of Sudarshan Pharma Industries is 40.8 As on 24 June, 2026 | 19:44
The PB ratio of Sudarshan Pharma Industries is 6.1 As on 24 June, 2026 | 19:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.